KNSA PEER ANALYSIS

Kiniksa Pharmaceuticals Ltd — metric-by-metric comparison with peers and the industry median

KNSAKiniksa Pharmaceuticals Ltd

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

KNSAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	KNSA	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
P/E	72.79	22.08●	—	—	46.82	31.28	21.37
P/B	8.78	4.32	-0.88●	0.80	3.47	1.98	1.82
EV/EBITDA	45.13	14.64	4.05●	33.84	14.07	19.15	12.26
P/S	7.05	3.93	0.21●	5.03	1.86	3.94	2.09

Financial Health
Metric	KNSA	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
Current Ratio	3.79●	3.66	1.32	1.73	1.33	0.92	2.22
Debt/Equity	1.5%	17.0%	-1,010.0%●	5.9%	41.0%	52.3%	46.3%
NetDebt/EBITDA	-4.26●	0.09	3.71	-0.10	1.10	3.50	1.24

Profitability
Metric	KNSA	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
Net Margin	9.7%	17.8%●	-13.5%	-3.6%	4.0%	12.6%	4.0%
ROE	13.7%	20.9%●	—	-0.6%	8.7%	6.3%	6.4%
ROA	10.3%	15.1%●	-4.7%	-0.5%	4.8%	3.2%	3.4%
EBITDA Margin	14.3%	27.0%	60.0%●	14.8%	14.3%	25.2%	18.2%

Growth + Dividend
Metric	KNSA	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
Rev. Growth	56.7%●	-3.4%	-9.9%	-2.3%	16.3%	-26.7%	7.5%
NI Growth	—	-5.9%	—	—	146.6%●	-14.2%	5.0%
Div. Yield	—	1.6%	0.0%	2.6%●	0.0%	2.0%	2.0%
Payout	—	36.3%	0.0%	-365.1%	0.0%	40.0%	0.8%

Valuation
Metric	KNSA	INDV	AMRX	LNTH	LQDA	HIMS	Ind. Median
P/E	72.79	20.45●	46.10	25.90	357.80	—	21.37
P/B	8.78	-35.65	-124.23●	5.96	73.50	18.83	1.82
EV/EBITDA	45.13	15.53	13.00●	15.56	147.65	292.27	12.26
P/S	7.05	3.98	1.85●	4.67	27.70	3.55	2.09

Financial Health
Metric	KNSA	INDV	AMRX	LNTH	LQDA	HIMS	Ind. Median
Current Ratio	3.79●	0.86	2.47	2.83	2.22	1.69	2.22
Debt/Equity	1.5%	-353.5%	-5,938.0%●	51.6%	170.2%	253.7%	46.3%
NetDebt/EBITDA	-4.26●	0.95	3.99	0.27	-0.71	12.68	1.24

Profitability
Metric	KNSA	INDV	AMRX	LNTH	LQDA	HIMS	Ind. Median
Net Margin	9.7%	19.4%●	4.0%	18.0%	7.7%	-0.6%	4.0%
ROE	13.7%	—	—	23.5%	28.2%●	-2.7%	6.4%
ROA	10.3%	19.5%●	3.5%	12.7%	7.1%	-0.8%	3.4%
EBITDA Margin	14.3%	27.3%	20.6%	30.6%●	18.7%	1.3%	18.2%

Growth + Dividend
Metric	KNSA	INDV	AMRX	LNTH	LQDA	HIMS	Ind. Median
Rev. Growth	56.7%	10.2%	7.6%	0.6%	1,936.7%●	32.8%	7.5%
NI Growth	—	1,830.8%●	—	9.7%	—	—	5.0%
Div. Yield	—	—	—	—	—	—	2.0%
Payout	—	—	—	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on KNSA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.